Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.
← catalyst calendarSponsored by Procter and Gamble (industry) · PG — their whole pipeline →.
Phase
Phase 2
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
120actual
Sites
1
Country
Canada
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-03-25 | actual | When the study began enrolling |
| Primary completion | 2025-06-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-19 | actual | The whole study's end, after follow-up |
| First posted | 2025-03-25 | actual | When this record first appeared on the registry |
| Results posted | 2026-05-04 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-05-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Gingivitis
Interventions
- Drug: Stannous Fluoride Dentifrice
- Drug: Sodium Fluoride Dentifrice
- Drug: Sodium monofluorophosphate dentifrice
Primary outcome
what the primary-completion date above is the date OFNumber Bleeding Sites
measured 4 weeks (~1 month) and 12 weeks (~3 months)
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2025-02-20 · 804 KB · Prot_SAP_001.pdf
Permalink · PG's whole pipeline · Catalyst calendar · Every registered study · What changed